Sakai Akinori
Department of Orthopaedic Surgery, University of Occupational and Environmental Health, Japan.
Clin Calcium. 2012 Mar;22(3):365-71.
Parathyroid hormone (PTH) is available for the treatment of osteoporosis in Japan. PTH is administered subcutaneously daily or weekly. According to the results of animal experiments, the anabolic action of PTH on bone depends on dosage, condition of loading, and region of bone. Administration of PTH preserved trabecular bone formation rate reduced by immobilization or unloading at the same level of that under the normal mobilization or loading condition, but at low dose did not preserve periosteal bone formation rate reduced by unloading. PTH at high dose (40μg/kg BW) completely preserved trabecular bone volume reduced by immobilization in mice. Thus, we consider that PTH could be clinically effective for immobilization- and/or unloading-induced bone loss.
在日本,甲状旁腺激素(PTH)可用于治疗骨质疏松症。PTH通过皮下注射,每日或每周给药一次。根据动物实验结果,PTH对骨骼的合成代谢作用取决于剂量、负荷条件和骨骼部位。给予PTH可使因固定或失负荷而降低的小梁骨形成率维持在正常活动或负荷条件下的相同水平,但低剂量时不能维持因失负荷而降低的骨膜骨形成率。高剂量(40μg/kg体重)的PTH可完全维持小鼠因固定而减少的小梁骨体积。因此,我们认为PTH对固定和/或失负荷引起的骨质流失可能具有临床疗效。